Journal of Neurotrauma · 2015 · 19 citations · 46 references
MedicineNeurosciencePharmacologyNeurochemistryNeuroimmunologyNeuropharmacologyNeuroinflammationNeuroprotectionNeurotoxic MechanismsNeurotoxicity MechanismsPost-traumatic SeizuresTraumatic Brain InjuryAcute NeuroinflammationImmunohistochemical BiomarkersNeuroprotective AgentsRodent Brain InjurySeizuresTraumatic Brain Injury NeuroprotectionTraumatic Brain Injury PathologyTraumatic Brain Injury-related Seizures
Post-traumatic seizures can exacerbate injurious outcomes of severe brain trauma, yet effective treatments are limited owing to the complexity of the pathology underlying the concomitant occurrence of both events. In this study, we tested C-10068, a novel deuterium-containing analog of (+)-N-methyl-3-ethoxymorphinan, in a rat model of penetrating ballistic-like brain injury (PBBI) and evaluated the effects of C-10068 on PBBI-induced nonconvulsive seizures (NCS), acute neuroinflammation, and neurofunctional outcomes. NCS were detected by electroencephalographic monitoring. Neuroinflammation was evaluated by immunohistochemical markers, for example, glial fibrillary acidic protein and major histocompatibility complex class I, for activation of astrocytes and microglia, respectively. Neurofunction was tested using rotarod and Morris water maze tasks. Three infusion doses of C-10068 (1.0, 2.5, and 5.0 mg/kg/h × 72 h) were tested in the antiseizure study. Neuroinflammation and neurofunction were evaluated in animals treated with 5.0 mg/kg/h × 72 h C-10068. Compared to vehicle treatment, C-10068 dose dependently reduced PBBI-induced NCS incidence (40-50%), frequency (20-70%), and duration (30-82%). The most effective antiseizure dose of C-10068 (5.0 mg/kg/h × 72 h) also significantly attenuated hippocampal astrocyte activation and perilesional microglial reactivity post-PBBI. Within C-10068-treated animals, a positive correlation was observed in reduction in NCS frequency and reduction in hippocampal astrocyte activation. Further, C-10068 treatment significantly attenuated astrocyte activation in seizure-free animals. However, C-10068 failed to improve PBBI-induced motor and cognitive functions with the dosing regimen used in this study. Overall, the results indicating that C-10068 exerts both potent antiseizure and antiinflammatory effects are promising and warrant further investigation.
46
An astrocytic basis of epilepsy
Guo-Feng Tian, Hooman Azmi, Takahiro Takano et al. · Nature Medicine · 2005 · 807 citations · Full text
Medicine, Neurobiology, Neuroscience +12
Acute seizures after intracerebral hemorrhage
Paul Vespa, K. O’Phelan, M. Mohsin Shah et al. · Neurology · 2003 · 559 citations
Medicine, Neurology, Neurosurgery +17